Showing results (301-310 of 630) with videos related to

Sort By:
Pageof 63
Immunotherapy|January 9, 2025
Lebrikizumab decreases type 2 inflammatory biomarker levels in patients with asthma: data from randomized phase 3 trials (LAVOLTA I and II)Stanley Szefler, Jonathan Corren, Jonathan I Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 21, 2022
Prevalence and associations of fatigue in childhood atopic dermatitis: A cross-sectional studyStephanie M Rangel, Theodore Kim, Anjani Sheth, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|September 29, 2020
Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema CouncilJonathan I Silverberg, Emma Guttman-Yassky, Tove Agner, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2019
How does parental history of atopic disease predict the risk of atopic dermatitis in a child? A systematic review and meta-analysisNina H Ravn, Anne-Sofie Halling, Aviva G Berkowitz, et al.
Dermatology and Therapy|April 22, 2025
The Association Between Atopic Dermatitis and Select Disease Events in Adults in the United States: A Retrospective Cohort Study in the Optum Electronic Health Records DatabaseAdina R Lemeshow, Alexander Egeberg, Thomas Edwards, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|September 21, 2018
Sleep Disturbance and Sleep-Related Impairment in Adults With Atopic Dermatitis: A Cross-sectional StudyJennifer C Li, Anna Fishbein, Vivek Singam, et al.
Paediatric Drugs|March 16, 2022
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 YearsThomas A Luger, Adelaide A Hebert, Andrea L Zaenglein, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 30, 2018
The effects of season and weather on healthcare utilization among patients with atopic dermatitisC R Hamann, Y M F Andersen, K A Engebretsen, et al.
Journal of Patient-Reported Outcomes|July 15, 2024
Capturing patient-reported sleep disturbance in atopic dermatitis clinical trialsCarla Dias-Barbosa, Jonathan I Silverberg, Sonja Ständer, et al.
Allergy|July 17, 2023
Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibitionEric L Simpson, Emma Guttman-Yassky, Lawrence F Eichenfield, et al.
Pageof 63